Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monotherapy levetiracetam in newly or recently diagnosed partial-onset epilepsy (Phase 3, open-label, randomized, multicenter)
2014-004377-16Phase 3
- Sponsor
- UCB
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of levetiracetam in Focal Onset Epilepsy and epilepsy, sponsored by UCB. Primary endpoint: Seizure freedom for 26 consecutive weeks.
02
Drugs
levetiracetam
03
Conditions
Focal Onset Epilepsyepilepsy
Beyond the preview
Go deeper on 2014-004377-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004377-16.